Online citations, reference lists, and bibliographies.

Epidemiology Of Infections In Cancer Patients

T. Zembower
Published 2014 · Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
Although major advances in the care of cancer patients over the past several decades have resulted in improved survival, infectious complications remain a significant cause of morbidity and mortality. To successfully identify, treat, and prevent infections, a comprehensive understanding of risk factors that predispose to infection and of commonly encountered pathogens is necessary. In addition, clinicians must keep abreast of the changing epidemiology of infections in this population. As therapeutic modalities continue to evolve, as established pathogens become increasingly drug resistant, and as new pathogens are discovered, successful management of infections will continue to present challenges in the years to come.
This paper references
10.1016/S0022-3476(99)70064-8
Viral infections in interferon-γ receptor deficiency☆☆☆
S. Dorman (1999)
10.1016/0002-9343(72)90008-3
Delayed hypersensitivity in Hodgkin's disease. A study of 103 untreated patients.
R. C. Young (1972)
Aerobic and anaerobic surgical wound contamination in patients with cancer.
Brummitte Dale Wilson (1974)
10.1371/journal.pone.0032945
Rhodococcus Bacteremia in Cancer Patients Is Mostly Catheter Related and Associated with Biofilm Formation
Fadi Al Akhrass (2012)
10.1016/S0167-8140(01)00328-0
Characterizing the phenomenon of radiation recall dermatitis.
R. Camidge (2001)
10.1016/j.idc.2010.01.007
Respiratory Viral Infections in Transplant and Oncology Patients
D. Kumar (2010)
10.1086/597400
Phaeohyphomycosis in a tertiary care cancer center.
R. Ben-Ami (2009)
10.1093/jac/21.suppl_C.149
Gram-positive infections in granulocytopenic patients: an important issue?
C. Viscoli (1988)
Infection in the cancer patient – diagnosis , prevention , and treatment
SC Schimpff (1995)
10.1086/523336
Impact of the intestinal microbiota on the development of mucosal defense.
H. Gaskins (2008)
10.1007/s11046-004-5495-0
Invasive filamentous fungal infections in allogeneic hematopoietic stem cell transplant recipients after recovery from neutropenia: Clinical, radiologic, and pathologic characteristics
A. Shaukat (2004)
10.7326/M13-2826
Advisory committee on immunization practices recommended immunization schedule for adults aged 19 years or older: United States, 2014.
C. Bridges (2014)
10.7326/0003-4819-91-4-539
Candida tropicalis: a major pathogen in immunocompromised patients.
J. Wingard (1979)
10.1002/1097-0142(19821001)50:7<1262::AID-CNCR2820500707>3.0.CO;2-F
Cancer chemotherapy associated symptomatic stomatitis. Role of herpes simplex virus (HSV)
K. Rand (1982)
10.1111/J.1365-2141.1999.01373.X
Do post‐splenectomy patients take prophylactic penicillin?
R. D. Keenan (1999)
10.3201/eid1011.040127
Burkholderia cenocepacia Vaginal Infection in Patient with Smoldering Myeloma and Chronic Hepatitis C
A. Petrucca (2004)
10.1001/jama.2008.824
Long-term all-cause mortality in cancer patients with preexisting diabetes mellitus: a systematic review and meta-analysis.
B. Barone (2008)
10.1002/1097-0142(19920101)69:1<17::AID-CNCR2820690106>3.0.CO;2-X
Neutropenic enterocolitis. Clinical diagnosis and treatment
D. Wade (1992)
Mechanisms of acquisition and development of bacterial infections in cancer patients
J Klastersky (1982)
10.1016/j.ijid.2008.06.032
Pyomyositis caused by extended-spectrum beta-lactamase-producing Escherichia coli in a patient with acute myeloid leukemia.
Sheng-Kang Chiu (2009)
10.1016/S0360-3016(02)03350-3
Candida glabrata is an emerging cause of oropharyngeal candidiasis in patients receiving radiation for head and neck cancer
Marta C Dahiya (2002)
10.1046/j.1365-2141.2001.02487.x
Cytomegalovirus infection and non‐neutropenic fever after autologous stem cell transplantation: high rates of reactivation in patients with multiple myeloma and lymphoma
A. Fassas (2001)
10.1128/AAC.00286-10
International Retrospective Analysis of 73 Cases of Invasive Fusariosis Treated with Voriconazole
O. Lortholary (2010)
10.1093/CLINIDS/14.4.875
Vascular catheter-associated fungemia in patients with cancer: analysis of 155 episodes.
J. Lecciones (1992)
10.1093/cid/cir073
Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the infectious diseases society of america.
A. Freifeld (2011)
Single-agent/combination therapy of human immunodeficiency virus-related wasting.
C. Wanke (1998)
10.1128/CMR.17.1.208-217.2004
Strongyloides stercoralis in the Immunocompromised Population
P. Keiser (2004)
Role of surgical treatment in the management of complications of the gastrointestinal tract in patients with leukemia.
H. Villar (1987)
10.1016/j.ajic.2009.02.002
Multidrug-resistant Escherichia coli bacteremia in cancer patients.
K. Vigil (2009)
10.1007/s11605-012-1930-6
Chemotherapy Patients with C. difficile Colitis Have Outcomes Similar to Immunocompetent C. difficile Patients
D. Stewart (2012)
10.1007/BF01961136
Three cases of infection withFusarium species in neutropenic patients
M. Nucci (2005)
10.1056/NEJM199111283252204
The incidence of zoster after immunization with live attenuated varicella vaccine. A study in children with leukemia. Varicella Vaccine Collaborative Study Group.
I. Hardy (1991)
10.1007/978-1-60761-644-3_1
Infections in Patients with Cancer: Overview
A. Safdar (2011)
10.1093/AJHP/60.15.1531
Monoclonal antibodies in the treatment of cancer, Part 1.
R. J. Cersosimo (2003)
10.1128/mmbr.27.1.72-86.1963
Cellular resistance to viral infection, with particular reference to endogenous interferon.
R. Wagner (1963)
10.1016/J.TRIPLEO.2003.09.008
Candida glabrata is an emerging cause of oropharyngeal candidiasis in patients receiving radiation for head and neck cancer.
S. Redding (2004)
10.1053/j.seminhematol.2009.03.008
Infections in patients with aplastic anemia.
Jessica M Valdez (2009)
Current concepts: immunology. Monocytes and macrophages.
R. Johnston (1988)
10.1016/J.BBI.2007.07.010
Understanding the interaction between psychosocial stress and immune-related diseases: A stepwise progression
M. Kemeny (2007)
10.1200/JCO.2012.45.5733
Central venous catheter care for the patient with cancer: American Society of Clinical Oncology clinical practice guideline.
C. Schiffer (2013)
10.1126/science.257.5073.1064
The Crisis in Antibiotic Resistance
H. Neu (1992)
10.1590/S1516-31802000000500004
Epidemiology of bloodstream infections at a cancer center.
E. Velasco (2000)
Host defense mechanisms against pathogens. Surg Infect 7(Suppl 2):S5– S7 (Larchmt) Epidemiology of Infections in Cancer Patients
RS Accolla (2006)
Infections with herpes simplex viruses
L Corey (1986)
10.1016/S0031-9384(02)00923-X
Stress, immune reactivity and susceptibility to infectious disease
A. Marsland (2002)
10.1258/0022215042244732
Cost and morbidity of MRSA in head and neck cancer patients: what are the consequences?
K. Watters (2004)
10.7326/0003-4819-77-5-707
Origin of infection in acute nonlymphocytic leukemia. Significance of hospital acquisition of potential pathogens.
S. Schimpff (1972)
Managing toxicities of high-dose interleukin-2.
R. Schwartz (2002)
10.1007/s00262-008-0598-y
Combination of active specific immunotherapy or adoptive antibody or lymphocyte immunotherapy with chemotherapy in the treatment of cancer
Tianqian Zhang (2008)
10.1001/JAMA.286.8.944
Should immunonutrition become routine in critically ill patients? A systematic review of the evidence.
D. Heyland (2001)
10.1016/0002-9343(87)90236-1
Multiple myeloma presenting with primary meningococcal arthritis.
M. Miller (1987)
10.1111/ajt.12233
Advisory Committee on Immunization Practices (ACIP) Recommended Immunization Schedule for Persons Aged 0 Through 18 Years—United States, 2013
Iyabode Akinsanya-Beysolow (2013)
10.1001/ARCHDERM.1993.01680290092014
Disseminated infection with Trichosporon beigelii. Report of a case and review of the cutaneous and histologic manifestations.
G. Nahass (1993)
10.1007/s00262-008-0576-4
Combinatorial treatments including vaccines, chemotherapy and monoclonal antibodies for cancer therapy
C. Baxevanis (2008)
10.1016/j.jinf.2009.06.002
A clinicopathological study of pulmonary mucormycosis in cancer patients: extensive angioinvasion but limited inflammatory response.
R. Ben-Ami (2009)
10.1111/ajt.12279
Advisory Committee on Immunization Practices (ACIP) Recommended Immunization Schedule for Adults Aged 19 Years and Older—United States, 2013
C. Bridges (2013)
10.1023/A:1007205402150
Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases
Ph.D. Joseph Heitman M.D. (2004)
Septicemia due to Streptococcus mitis in neutropenic patients with acute leukemia
M Arning (1990)
Central venous catheter care for the patient with cancer
C A Schiffer (2013)
10.1016/0002-9343(81)90162-5
Fungemia in the immunocompromised host. Changing patterns, antigenemia, high mortality.
F. Meunier-Carpentier (1981)
10.1086/605630
Hospital and societal costs of antimicrobial-resistant infections in a Chicago teaching hospital: implications for antibiotic stewardship.
R. Roberts (2009)
10.1128/JCM.44.1.160-165.2006
Viridans Streptococci Isolated by Culture from Blood of Cancer Patients: Clinical and Microbiologic Analysis of 50 Cases
X. Han (2006)
10.1097/QCO.0b013e328335b004
The role of keratinocytes in defense against infection
J. Schröder (2010)
10.1002/cncr.20554
Aspergillus terreus
R. Hachem (2004)
10.1093/CLINIDS/15.1.33
Streptococcal and enterococcal bacteremia in patients with cancer.
A. Awada (1992)
10.1097/NAN.0b013e31820b8a3e
Consensus Conference on Prevention of Central Line-Associated Bloodstream Infections: 2009
John Segreti (2011)
10.1053/JHIN.2002.1356
Outbreak of Clostridium difficile-related diarrhoea in an adult oncology unit: risk factors and microbiological characteristics.
E. Blot (2003)
10.1007/BF01967791
Role of human microflora in health and disease
C. Tancrède (2005)
Immune defense against bacterial pathogens: innate immunity
K Todar (2008)
Immune defense against bacterial pathogens: adaptive or acquired immunity
K Todar (2008)
10.1186/1471-2334-8-80
Emergence of Carbapenem resistant Gram negative and vancomycin resistant Gram positive organisms in bacteremic isolates of febrile neutropenic patients: A descriptive study
S. Irfan (2008)
10.7326/0003-4819-64-2-328
Quantitative relationships between circulating leukocytes and infection in patients with acute leukemia.
G. Bodey (1966)
Nosocomial fungal infections. Old problems and new challenges.
E. Anaissie (1989)
10.1016/S0002-9343(89)80836-8
Mucormycosis: association with deferoxamine therapy.
G. Daly (1989)
10.1016/B978-1-4557-4801-3.00302-7
302 – Infections Caused by Percutaneous Intravascular Devices
S. Beekmann (2015)
10.1093/CLINIDS/14.SUPPLEMENT_1.S43
Opportunistic mycoses in the immunocompromised host: experience at a cancer center and review.
E. Anaissie (1992)
Strategies for the prevention of infection in the myelosuppressed or immunosuppressed cancer patient.
P. Pizzo (1983)
10.1097/00005792-197605000-00005
CAUSES OF DEATH IN ADULTS WITH ACUTE LEUKEMIA
Hui‐Yen Chang (1976)
10.1016/j.jss.2010.03.063
Obese patients benefit from minimally invasive colorectal cancer surgery.
C. Balentine (2010)
10.1007/s00520-007-0398-5
Emergence of MRSA in positive blood cultures from patients with febrile neutropenia—a cause for concern
P. Morris (2007)
Proceedings: Causes of death in cancer patients.
J. Inagaki (1974)
10.1016/S1040-8428(84)80008-6
Monoclonal antibodies in the treatment of cancer.
R. Dillman (1984)
10.1016/j.bbmt.2010.05.008
The changing epidemiology of vancomycin-resistant Enterococcus (VRE) bacteremia in allogeneic hematopoietic stem cell transplant (HSCT) recipients.
Mini Kamboj (2010)
10.1001/JAMA.1992.03480060078034
Pneumocystis carinii pneumonia among patients without AIDS at a cancer hospital.
K. Sepkowitz (1992)
10.1093/CLINIDS/13.6.1077
Disseminated infection with Fusarium in recipients of bone marrow transplants.
A. Gamis (1991)
10.1016/s0140-6736(70)91715-0
Deaf-mutism and type-II hyperlipoproteinaemia.
Raphael Ss (1970)
10.1542/pir.29-1-5
Varicella-zoster virus infections.
A. Gershon (2008)
Risk assessment and the management of neutropenic fever
KV Rolston (2009)
10.1007/978-1-4615-2490-8
Clinical Approach to Infection in the Compromised Host
R. Rubin (1994)
10.1016/S0190-9622(86)70121-7
Genital white piedra: epidemiology, microbiology, and therapy.
D. C. Kalter (1986)
10.1007/978-94-009-1093-5_19
Infection in the Patient with Cancer
Stephen C. Schimpff (1989)
Medical care of cancer patients. People's Medical Publishing House
K V Rolston (2009)
10.1146/annurev.mi.42.100188.002301
Microbial ecology of the skin.
R. R. Roth (1988)
10.1001/jama.1965.03090020019005
CAUSES OF DEATH IN ACUTE LEUKEMIA: A TEN-YEAR STUDY OF 414 PATIENTS FROM 1954-1963.
E. Hersh (1965)
10.1086/599376
Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 Update by the Infectious Diseases Society of America.
L. Mermel (2009)
10.1093/infdis/138.2.227
Sources of gram-negative bacilli colonizing the tracheae of intubated patients.
S. N. Schwartz (1978)
10.1093/infdis/137.1.14
Three antibiotic regimens in the treatment of infection in febrile granulocytopenic patients with cancer. The EORTC international antimicrobial therapy project group.
S. Schimpff (1978)
10.1001/JAMA.1992.03480090085032
Severe measles in immunocompromised patients.
L. J. Kaplan (1992)
Immunoglobulin synthesis and tumor kinetics of multiple myeloma.
S. Salmon (1973)
Emergence of multidrug resistant acinetobacter blood stream infections in febrile neutropenia patients with haematological cancers and bone marrow failure syndromes.
Prashant Sood (2012)
10.1002/1097-0142(197612)38:6<2343::AID-CNCR2820380621>3.0.CO;2-T
Preoperative cell‐mediated immune status of gastric cancer patients
K. Orita (1976)
10.1097/SLA.0b013e3181dae4ed
Postoperative Complications Following Surgery for Rectal Cancer
Bogdan C. Paun (2010)
Opportunistic invasive fungal infections in patients with leukaemia lymphoma.
Krick Ja (1976)
10.1007/s00595-009-4011-z
Retrospective, matched case-control study comparing the oncologic outcomes between laparoscopic surgery and open surgery in patients with right-sided colon cancer
T. Nakamura (2009)
10.3816/CLML.2010.n.009
Progressive multifocal leukoencephalopathy in chronic lymphocytic leukemia: a report of three cases and review of the literature.
A. D’Souza (2010)
10.1038/nrclinonc.2012.1
Reactivation of hepatitis B virus and hepatitis C virus in patients with cancer
H. Torres (2012)
10.3389/fimmu.2011.00088
Activation of Natural Killer Cells during Microbial Infections
Amir Horowitz (2012)
10.2174/157489110790112608
Clostridium difficile infection following chemotherapy.
S. Raza (2010)
10.1016/S0140-6736(71)92448-2
Reduced lymphocyte transformation in breast cancer.
M. Whittaker (1971)
10.1093/INFDIS/164.5.907
Ceftazidime monotherapy for empiric treatment of febrile neutropenic patients: a meta-analysis.
J. Sanders (1991)
10.1007/978-1-60761-644-3_10
Catheter-Related Infections in Cancer Patients
Iba Al Wohoush (2011)
10.1007/BF01967060
Fungal infections in cancer patients: An international autopsy survey
G. Bodey (2005)
Viral infections in interferon-gamma receptor deficiency
SE Dorman (1999)
10.1086/497832
Invasive Saccharomyces infection: a comprehensive review.
A. Enache-Angoulvant (2005)
10.1007/978-1-4615-6642-7_2
Epidemiology and Prevention of Infection in the Compromised Host
J. C. Wade (1988)
10.1007/978-1-4613-1239-0_3
Chemoprophylaxis for the prevention of bacterial and fungal infections.
J. Donnelly (1995)
10.1097/00062752-199502060-00002
Immune recovery after bone marrow transplantation
C. Lenarsky (1995)
10.1159/000099632
An Ambiguous Phenomenon of Radiation and Drugs: Recall Reactions
M. Çaloğlu (2007)
10.1093/jac/dkq437
Risk assessment and prognostic factors for mould-related diseases in immunocompromised patients.
L. Pagano (2011)
10.1007/978-1-4684-5535-9_4
The binding of antigen presenting cells to T lymphocytes.
R. Steinman (1988)
Fatal Yersinia enterocolitica sepsis after blood transfusion.
D. Wright (1985)
10.1046/J.1537-2995.1993.331194082380.X
A prospective microbiologic surveillance program to detect and prevent the transfusion of bacterially contaminated platelets.
R. Yomtovian (1993)
10.1093/CLINIDS/14.6.1201
Septicemia and shock syndrome due to viridans streptococci: a case-control study of predisposing factors.
L. Elting (1992)
Incidence et facteurs de risque d'infections du site opératoire en chirurgie carcinologique mammaire.
D. Lefebvre (2000)
The role of immunonutrition in gynecologic oncologic surgery.
J. Celik (2009)
10.1016/0002-9343(63)90140-2
INFECTION, ANTIBODY RESPONSE AND GAMMA GLOBULIN COMPONENTS IN MULTIPLE MYELOMA AND MACROGLOBULINEMIA.
J. Fahey (1963)
10.1084/jem.136.6.1631
DEPRESSED CELL-MEDIATED IMMUNITY IN PATIENTS WITH PRIMARY INTRACRANIAL TUMORS
W. Brooks (1972)
10.1182/blood.v75.7.1583.bloodjournal7571583
Immunoglobulin G subclass deficiency and pneumococcal infection after allogeneic bone marrow transplantation.
J. Sheridan (1990)
10.1053/j.seminhematol.2006.09.016
Emerging Infectious Diseases That Threaten the Blood Supply
H. Alter (2007)
10.1016/j.biologicals.2009.01.002
Transfusion-transmitted infectious diseases.
Jean-Pierre Allain (2009)
10.1016/B978-1-4557-4801-3.00310-6
Prophylaxis and Empirical Therapy of Infection in Cancer Patients
E. Castagnola (2015)
10.1245/s10434-010-0923-5
Characteristics and Outcomes of Methicillin-Resistant Staphylococcus aureus Surgical-Site Infections in Patients with Cancer: a Case–Control Study
R. Chemaly (2010)
Infections with herpes simplex viruses (2).
L. Corey (1986)
10.1093/jnci/75.6.1017
Natural killer cytotoxic factor induction by K562 cells in patients with advanced cancer: correlation with production of interferon.
E. Steinhauer (1985)
10.1067/MJD.2003.87
Dermatologic side effects of thalidomide in patients with multiple myeloma.
V. C. Hall (2003)
10.1007/S10227-001-0156-0
Histopathologic Features Seen with Radiation Recall or Enhancement Eruptions
K. Smith (2002)
10.1093/clinids/9.5.1013
Disseminated infection with Trichosporon beigelii.
D. Walling (1987)
10.1002/AJH.10267
Hairy cell leukemia with concurrent cryptococcus infection
Y. Audeh (2003)
10.1002/1097-0142(197703)39:3<1018::AID-CNCR2820390304>3.0.CO;2-N
Infections in patients with malignant lymphoma treated with combination chemotherapy
R. Feld (1977)
10.1016/S0749-0704(05)70206-2
Nutritional support in critically ill patients with cancer.
P. Wong (2001)
10.1016/j.ajic.2011.01.003
Guidelines for the prevention of intravascular catheter-related infections.
N. O'grady (2011)
Nutrition in cancer care ( PDQ ) health professional version . 30 Dec 2009
MM MarinCaro (2009)
10.7326/0003-4819-85-3-294
Adriamycin and enhanced radiation reaction in normal esophagus and skin.
F. Greco (1976)
10.7326/0003-4819-96-5-601
Successful chemotherapy of transfusion babesiosis.
M. Wittner (1982)
10.1016/0002-9343(81)90208-4
Invasive aspergillosis. Progress in early diagnosis and treatment.
B. Fisher (1981)
10.1086/649858
Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the infectious diseases society of america.
J. Perfect (2010)
10.1016/S1473-3099(10)70218-8
Emerging opportunistic yeast infections.
M. Miceli (2011)
10.1007/978-1-4613-1239-0_1
Factors predisposing cancer patients to infection.
C. Viscoli (1995)
10.1080/10428190902730219
Infectious complications of rituximab in patients with lymphoma during maintenance therapy: a systematic review and meta-analysis
S. Aksoy (2009)
10.3109/00365548.2010.544669
Clinical outcome of catheter salvage in neutropenic cancer patients with catheter-related infection
E. Joo (2011)
10.1093/CLINIDS/17.6.1018
Fluconazole-resistant Candida albicans.
D. Boken (1993)
10.1093/CLINIDS/12.6.997
Nosocomial infections due to Xanthomonas maltophilia (Pseudomonas maltophilia) in patients with cancer.
N. Khardori (1990)
10.1056/NEJM198911303212202
Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A, non-B hepatitis.
H. Alter (1989)
10.1007/s00595-006-3320-8
Favorable Effects of Preoperative Enteral Immunonutrition on a Surgical Site Infection in Patients with Colorectal Cancer Without Malnutrition
H. Horie (2006)
10.1128/jcm.24.4.581-584.1986
Increased incidence of fungemia caused by Candida krusei.
W. Merz (1986)
10.1016/S0889-8588(05)70244-6
Biologic response modifiers in pediatric cancer.
L. Worth (2001)
10.1016/S0022-3468(99)90565-1
The morbidity and mortality of pediatric splenectomy: does prophylaxis make a difference?
M. Jugenburg (1999)
10.1038/bjc.1989.167
Patients at risk of chemotherapy-associated toxicity in small cell lung cancer.
L. Morittu (1989)
Psychosocial factors and susceptibility to or outcome of acute respiratory tract infections.
M. Falagas (2010)
10.1016/0002-9343(86)90634-0
Disseminated atypical mycobacterial infection in patients with hairy cell leukemia.
C. Bennett (1986)
Unusual nosocomial pathogens.
K. Mayer (1989)
10.1002/cncr.23466
The changing epidemiology of invasive candidiasis
R. Hachem (2008)
10.1002/1097-0142(19820701)50:1<187::AID-CNCR2820500134>3.0.CO;2-Y
Rates of hospital‐acquired bloodstream infections in patients with specific malignancy
J. Mayo (1982)
10.1111/j.1423-0410.1984.tb01555.x
Diseases transmissible by blood transfusion.
J. Soulier (1984)
10.1093/CLINIDS/13.3.496
Empiric therapy with amphotericin B in febrile granulocytopenic patients.
T. Walsh (1991)
10.1002/mus.880010603
A clinical review
I. M. Siegel (1978)
10.1007/978-1-4899-3077-4_8
Clinical diagnosis and treatment
Gerald Bennett (1994)
10.1016/S0025-7125(16)31284-6
Therapy of infection in patients with granulocytopenia.
S. Schimpff (1977)
10.7326/0003-4819-100-3-345
Prolonged granulocytopenia: the major risk factor for invasive pulmonary aspergillosis in patients with acute leukemia.
S. Gerson (1984)
10.1016/0002-9343(80)90259-4
Infections of hairy cell leukemia. Clinical evidence of a pronounced defect in cell-mediated immunity.
P. Mackowiak (1980)
10.1111/j.1600-0714.2010.00937.x
Epidemiology of oral yeast colonization and infection in patients with hematological malignancies, head neck and solid tumors.
S. Schelenz (2011)
10.4084/MJHID.2012.070
Infectious Complications in Chronic Lymphocytic Leukemia
A. Nosari (2012)
10.1099/VIR.0.18709-0
Virus complement evasion strategies.
H. Favoreel (2003)
10.1007/s15010-010-0023-2
Clinical characteristics of Stenotrophomonas maltophilia infection in hematopoietic stem cell transplantation recipients: a single center experience
M. Yeshurun (2010)
10.7326/0003-4819-95-5-549
Infections during intensive chemotherapy for non-Hodgkin's lymphoma.
J. Bishop (1981)
Escherichia coli pyomyositis in an immunocompromised host.
U. Sharma (2011)
10.1001/JAMA.1992.03480100060031
Infections complicating mycosis fungoides and Sézary syndrome.
P. Axelrod (1992)
10.1086/426816
Comparing interferon- gamma release assay with tuberculin skin test readings at 48-72 hours and 144-168 hours with use of 2 commercial reagents.
David Tat (2005)
Changing Patterns, Antigenemia, High Mortality
F. Meunier-Carpentier (1981)
10.1016/j.bjoms.2007.12.013
Which patients are most at risk of methicillin resistant Staphylococcus aureus: a review of admissions to a regional maxillofacial ward between 2001 and 2005.
S. Rogers (2008)
10.1086/599346
Chemotherapy treatment in pediatric patients with acute myeloid leukemia receiving antimicrobial prophylaxis leads to a relative increase of colonization with potentially pathogenic bacteria in the gut.
Michel J. van Vliet (2009)
10.1586/eri.10.95
Clostridium difficile infection in cancer patients and hematopoietic stem cell transplant recipients
T. Chopra (2010)
10.1371/journal.ppat.1002619
The Role of Mast Cells in the Defence against Pathogens
M. Urb (2012)
10.1038/nchembio.1186
Induction of innate and adaptive immunity by delivery of poly dA:dT to dendritic cells.
Scott Barbuto (2013)
10.1016/S0140-6736(84)91891-9
FIVE CASES OF PSEUDOMONAS SEPSIS TRANSMITTED BY BLOOD TRANSFUSIONS
E. Tabor (1984)
10.1093/clinids/11.5.677
Infection and cyclosporine.
J. Kim (1989)
10.1002/1097-0142(197607)38:1<149::AID-CNCR2820380124>3.0.CO;2-Q
Immune evaluation with skin testing. A study of testicular, prostatic, and bladder neoplasms
P. Schellhammer (1976)
10.1086/605664
Infections in patients with multiple myeloma in the era of high-dose therapy and novel agents.
M. Nucci (2009)
10.7326/0003-4819-114-10-917_2
ABC of transfusion
Abd El Salam El Askary (2009)
10.1097/00000658-197307000-00006
Hartmann Procedure for Carcinoma of the Sigmoid and Rectum
Robert D. Goncaware (1973)
10.1016/0002-9343(81)90781-6
Nosocomial infections in immunocompromised children.
W. Hughes (1981)
10.1097/00004347-198303000-00007
Genital condyloma virus infection following pelvic radiation therapy: report of seven cases.
D. Lowell (1983)
10.1093/jac/dkp411
Bacteraemia due to extended-spectrum beta-lactamase-producing Escherichia coli (ESBL-EC) in cancer patients: clinical features, risk factors, molecular epidemiology and outcome.
C. Gudiol (2010)
10.1111/j.1600-0609.2009.01259.x
Risk factors for severe infection in patients with hairy cell leukemia: a long‐term study of 73 patients
G. Damaj (2009)
10.1245/ASO.2003.07.023
Prospective Identification of Risk Factors for Wound Infection After Lower Extremity Oncologic Surgery
C. Morris (2003)
10.1093/cid/cir257
Guidelines for the prevention of intravascular catheter-related infections.
N. O'grady (2011)
10.1001/archinte.1986.00360220101019
Adherent microorganisms on lumenal surfaces of long-term intravenous catheters. Importance of Staphylococcus epidermidis in patients with cancer.
J. Tenney (1986)
10.1007/s11739-010-0456-8
Infectious complications in neutropenic cancer patients
Francesco Menichetti (2010)
10.1097/00005792-198607000-00005
Trichosporonosis in Patients with Neoplastic Disease
T. Walsh (1986)
10.1097/MCO.0b013e3281e2c983
Impact of nutrition on quality of life during cancer
M. M. Marín Caro (2007)
10.1111/j.1423-0410.2009.01134.x
Microbiology, time course and clinical characteristics of infection in critically ill patients receiving packed red blood cell transfusion.
J-S Rachoin (2009)
10.1111/j.1572-0241.1999.01115.x
Clostridium difficile Colitis
S. Meyers (1999)
10.1097/QCO.0b013e328355660b
Community acquired respiratory and gastrointestinal viral infections: challenges in the immunocompromised host
A. Kaltsas (2012)
10.1016/j.tim.2011.07.010
Cryptococcus gattii: a resurgent fungal pathogen.
V. Chaturvedi (2011)
10.1007/s00520-005-0898-0
Causes of fever in cancer patients (prospective study over 477 episodes)
E. Toussaint (2005)
10.1093/CLINIDS/17.1.109
Clostridium difficile infection associated with antineoplastic chemotherapy: a review.
A. Anand (1993)
10.1093/CLINIDS/14.SUPPLEMENT_1.S120
Candidemia in immunocompromised patients.
F. Meunier (1992)
10.1182/BLOOD-2002-10-3143
Transfusion-transmitted cytomegalovirus infection after receipt of leukoreduced blood products.
W. G. Nichols (2003)
10.1007/s00520-010-0892-z
A systematic review of oral fungal infections in patients receiving cancer therapy
R. Lalla (2010)
10.2174/187221308784543647
Psychosocial stress, emotions and cytokine-related disorders.
A. Aubert (2008)
10.2337/dc10-0666
Diabetes and Cancer
E. Giovannucci (2010)
Mucormycosis in hematologic patients.
L. Pagano (2004)
10.7326/0003-4819-108-2-221
NIH conference. Varicella-zoster virus infections. Biology, natural history, treatment, and prevention.
S. Straus (1988)
10.1056/NEJM198101293040501
Opsonic requirements for intravascular clearance after splenectomy.
S. Hosea (1981)
10.1016/J.IJANTIMICAG.2007.06.014
The epidemiology and treatment of infections in cancer patients.
G. Maschmeyer (2008)
10.1016/j.semcancer.2011.12.009
Monoclonal antibodies for the treatment of cancer.
C. W. Shuptrine (2012)
Nutrition in cancer care (PDQ) health professional version
10.1007/BF02796205
Infections in acute leukemia: an analysis of 240 febrile episodes
R. Jagarlamudi (2000)
10.4065/75.10.1039
Infection and immunity in chronic lymphocytic leukemia.
S. Tsiodras (2000)
10.1046/J.1525-1438.1999.99065.X
Fulminant Clostridium difficile colitis associated with paclitaxel and carboplatin chemotherapy.
E. Resnik (1999)
10.1002/1097-0142(197402)33:2<568::AID-CNCR2820330236>3.0.CO;2-2
Causes of death in cancer patients
J. Inagaki (1974)
10.1001/archpedi.1971.02110040067003
Fatal infections in childhood leukemia.
W. Hughes (1971)
10.1016/0002-9343(86)90257-3
Empiric use of vancomycin during prolonged treatment-induced granulocytopenia. Randomized, double-blind, placebo-controlled clinical trial in patients with acute leukemia.
J. Karp (1986)
High incidence of acute postoperative meningitis and septicemia in patients undergoing craniotomy with ventriculoatrial shunt.
H. Naito (1973)
10.1016/0002-9343(75)90230-2
Infections in 92 splenectomized patients with Hodgkin's disease. A clinical review.
S. Schimpff (1975)
10.1057/9781137031792_4
Old Problems and New Challenges
Miriam Joyce (2012)
10.1128/AAC.35.11.2302
Development of resistance in candida isolates from patients receiving prolonged antifungal therapy.
P. Fan-Havard (1991)
Clinical Evidence of a Pronounced Defect in Cell-Mediated Immunity
Philip A. Mackowiak (1980)
10.1056/NEJM199501193320303
Age, thymopoiesis, and CD4+ T-lymphocyte regeneration after intensive chemotherapy.
C. Mackall (1995)
10.1056/NEJM198603133141105
Infections with herpes simplex viruses (1).
L. Corey (1986)
10.1001/archinte.1983.00350010034007
Coagulase-negative staphylococcal bacteremia in patients receiving immunosuppressive therapy.
D. Winston (1983)
10.1056/NEJM199110313251803
Increase in Candida krusei infection among patients with bone marrow transplantation and neutropenia treated prophylactically with fluconazole.
J. Wingard (1991)
10.5555/uri:pii:0093775486900047
Immunosuppression and infection in multiple myeloma.
D. Jacobson (1986)
10.1086/502602
Risk factors for acquisition of Clostridium difficile-associated diarrhea among outpatients at a cancer hospital.
T. Palmore (2005)
10.3201/eid1702.101020
Risk Factors for Cryptococcus gattii Infection, British Columbia, Canada
L. MacDougall (2011)
10.1158/1055-9965.EPI-08-0792
The Human Microbiome Project: Getting to the Guts of the Matter in Cancer Epidemiology
J. Lampe (2008)
10.1007/s00268-003-7193-3
Surgical Site Infections in Breast Surgery: Case-control Study
D. Vilar-Compte (2003)
10.1089/SUR.2006.7.S2-5
Host defense mechanisms against pathogens.
R. Accolla (2006)
10.1007/s005200000143
Infectious complications of advanced cancer
J. Homsi (2014)
10.1002/cncr.24507
Candidemia in patients with hematologic malignancies in the era of new antifungal agents (2001‐2007)
N. Sipsas (2009)
10.1017/S0022172400023615
Determination of the colonization resistance of the digestive tract of individual mice.
D. van der Waaij (1974)
10.1086/649866
Escherichia coli Pyomyositis: an emerging infectious disease among patients with hematologic malignancies.
K. Vigil (2010)
10.1159/000321018
Emerging Resistant Gram-Negative Aerobic Bacilli in Hospital-Acquired Infections
Anjali N. Kunz (2010)
10.1038/sj.bjc.6605578
Prevalence, risk factors and clinical implications of malnutrition in French Comprehensive Cancer Centres
M. Pressoir (2010)
Aerobic and anaerobic surgical wound contamination in patients with cancer.
Wilson Bd (1974)
Immunoglobulin synthesis and tumor kinetics of multiple myeloma.
Salmon Se (1973)
Infection in the cancer patient – diagnosis , prevention , and treatment
GL Mandell (1995)
10.1111/J.1469-0691.2007.01841.X
Changes in Escherichia coli resistance patterns during and after antibiotic therapy: a longitudinal study among outpatients in Germany.
E. Raum (2008)
10.1056/NEJM198606193142501
Prophylaxis with oral penicillin in children with sickle cell anemia. A randomized trial.
M. H. Gastón (1986)
10.1007/S11908-008-0017-8
New horizons for the infectious diseases specialist: How gut microflora promote health and disease
Shervin Rabizadeh (2008)
10.1086/519932
Outcomes for and risk factors associated with vancomycin-resistant Enterococcus faecalis and vancomycin-resistant Enterococcus faecium bacteremia in cancer patients.
G. Ghanem (2007)
Risk factors for, and clinical relevance of, faecal extended-spectrum beta-lactamase producing Escherichia coli (ESBL-EC) carriage in neutropenic patients with haematological malignancies
M Arnan (2011)
Clinical features and complications of viridans streptococci bloodstream infection in pediatric hemato-oncology patients.
W. Huang (2007)
10.1016/0278-5846(87)90051-0
Behavioral influences on the immune system: Stress and conditioning
Jill Irwin (1987)
10.1016/0002-9343(82)90334-5
Fungal infections in patients with acute leukemia.
M. Degregorio (1982)
10.1182/BLOOD.V84.7.2221.BLOODJOURNAL8472221
Lymphocyte depletion during treatment with intensive chemotherapy for cancer.
C. Mackall (1994)
Infections in haematologic neoplasms: autopsy findings.
A. Nosari (1991)
10.1002/cncr.20604
Bacteremia caused by Achromobacter and Alcaligenes species in 46 patients with cancer (1989–2003)
G. Aisenberg (2004)
10.1002/cncr.22666
Infectious complications of monoclonal antibodies used in cancer therapy
P. Rafailidis (2007)
Toxoplasmosis of the central nervous system.
J. Meredith (1987)
10.1097/00006454-198505000-00038
AIDS--an immunologic reevaluation.
M. Seligmann (1984)
10.1016/0002-9343(76)90026-7
Torulopsis glabrata infections in patients with cancer. Increasing incidence and relationship to colonization.
J. Aisner (1976)
10.1093/cid/cis550
Enterococcal bacteremia is associated with increased risk of mortality in recipients of allogeneic hematopoietic stem cell transplantation.
J. Vydra (2012)
10.7326/0003-4819-119-12-199312150-00003
Infectious Morbidity Associated with Long-Term Use of Venous Access Devices in Patients with Cancer
J. Groeger (1993)
10.1128/JCM.01747-08
Results from the ARTEMIS DISK Global Antifungal Surveillance Study, 1997 to 2007: 10.5-Year Analysis of Susceptibilities of Noncandidal Yeast Species to Fluconazole and Voriconazole Determined by CLSI Standardized Disk Diffusion Testing
M. Pfaller (2008)
10.7326/0003-4819-110-12-1001
Transplanted infections: donor-to-host transmission with the allograft.
K. Gottesdiener (1989)
Supportive care in hematologic malignancies, in Wintrobe’s clinical hematology
M Vusirikala (2009)
10.1080/15476910801897920
Adverse Consequences of Immunostimulation
Rafael Ponce (2008)
10.1016/S1470-2045(04)01597-9
Stress, depression, the immune system, and cancer.
E. Reiche (2004)
10.1016/0002-9343(80)90262-4
Adenovirus infection in the immunocompromised patient.
J. M. Zahradnik (1980)
10.3816/CLM.2009.n.071
Infectious complications in patients with chronic lymphocytic leukemia: pathogenesis, spectrum of infection, and approaches to prophylaxis.
V. Morrison (2009)
10.1128/jcm.21.3.464-466.1985
Neisseria meningitidis serogroup 29E (Z') septicemia in a patient with far advanced multiple myeloma (plasma cell leukemia).
E. Wachter (1985)
10.1128/IAI.00953-12
Natural Killer Cells Protect against Mucosal and Systemic Infection with the Enteric Pathogen Citrobacter rodentium
L. Hall (2012)
10.1016/0305-7372(93)90011-F
Pneumocystis carinii pneumonia in cancer patients.
I. Varthalitis (1993)
Infections with herpes simplex viruses. (Second of two parts)
L. Corey (1986)
10.1056/NEJM198803243181205
Monocytes and Macrophages
R. Johnston (1988)
[Candidiasis among non-neutropenic patients: from colonization to infection].
P. Eggimann (2001)
10.1016/S0360-3016(03)00415-2
Oropharyngeal candidiasis caused by non-albicans yeast in patients receiving external beam radiotherapy for head-and-neck cancer.
Marta C Dahiya (2003)
10.1007/978-1-60761-644-3
Principles and Practice of Cancer Infectious Diseases
Amar Safdar (2011)
Biological response modifiers in cancer.
P. Reang (2006)
10.1016/j.diabet.2012.01.002
Diabetes and mucormycosis: a complex interplay.
B. Rammaert (2012)
Todar's Online Textbook of Bacteriology
H. Darmani (2006)
10.1186/1752-1947-3-93
Radiation recall dermatitis with soft tissue necrosis following pemetrexed therapy: a case report
Christian Spirig (2009)
10.7326/0003-4819-116-1-55
Reducing the risk for transfusion-transmitted cytomegalovirus infection.
M. Sayers (1992)
[Infections in multiple myeloma].
J. San Miguel (1983)
10.2337/dc09-1721
Postoperative Mortality in Cancer Patients With Preexisting Diabetes
B. Barone (2010)
10.1002/1097-0142(197209)30:3<616::AID-CNCR2820300304>3.0.CO;2-Q
Immunologic impairment in bronchogenic carcinoma: A study of lymphocyte response to phytohemagglutinin
T. Han (1972)
10.1002/1097-0142(197804)41:4<1610::AID-CNCR2820410452>3.0.CO;2-B
Fever and infection in leukemic patients. A study of 494 consecutive patients
Gerald P. Bodey (1978)
10.1007/s15010-010-0017-0
An outbreak of Burkholderia cenocepacia bacteremia in immunocompromised oncology patients
T. Mann (2010)
10.1093/CLINIDS/17.SUPPLEMENT_2.S416
Pneumocystis carinii pneumonia in patients without AIDS.
K. Sepkowitz (1993)
10.1093/jac/dkn514
Analysis of 4758 Escherichia coli bacteraemia episodes: predictive factors for isolation of an antibiotic-resistant strain and their impact on the outcome.
M. Ortega (2009)
10.1007/s10096-010-1093-x
Risk factors for, and clinical relevance of, faecal extended-spectrum β-lactamase producing Escherichia coli (ESBL-EC) carriage in neutropenic patients with haematological malignancies
M. Arnan (2010)
10.1016/S0140-6736(76)93046-4
SERUM-COBALT
J. Versieck (1976)
10.1016/S0750-7658(01)00374-4
Candidoses du sujet non neutropnique: de la colonisation linfection
P. Eggimann (2001)
10.1080/00016480600750018
Clinical features of head and neck cancer patients with methicillin-resistant Staphylococcus aureus
T. Shiomori (2007)
10.1007/s00277-012-1539-6
Daptomycin nonsusceptible enterococci in hematologic malignancy and hematopoietic stem cell transplant patients: an emerging threat
Kitsada Wudhikarn (2012)
10.1093/jac/dkm514
Recent changes in bacterial epidemiology and the emergence of fluoroquinolone-resistant Escherichia coli among patients with haematological malignancies: results of a prospective study on 823 patients at a single institution.
C. Cattaneo (2008)
Mechanisms of acquisition and development of bacterial infections in cancer patients. In: Klastersky J (ed) Infections in cancer patients
MP Glauser (1982)
10.1007/s10350-008-9395-0
Visceral Obesity Predicts Surgical Outcomes after Laparoscopic Colectomy for Sigmoid Colon Cancer
S. Tsujinaka (2008)
10.1093/clinids/13.1.139
Rhodococcus equi infection in patients with and without human immunodeficiency virus infection.
R. Harvey (1991)
10.1136/bmj.300.6722.450
ABC of transfusion. Infectious complications of blood transfusion: viruses.
J. Barbara (1990)
10.1016/j.jamcollsurg.2008.08.032
Effect of body mass index on short-term outcomes after colectomy for cancer.
R. Merkow (2009)
10.1007/s00125-012-2526-0
Diabetes and cancer (2): evaluating the impact of diabetes on mortality in patients with cancer
A. Renehan (2012)
[Hairy cell leukemia].
A. M. Polianskaia (1983)
10.1007/0-306-47527-8_2
Defects in Host-Defense Mechanisms
J. W. M. Meer (1988)
10.1186/1471-2164-10-380
The degree of microbiome complexity influences the epithelial response to infection
J. J. Mans (2008)
10.1016/j.jinf.2010.01.010
Invasive fusariosis in patients with hematologic malignancies at a cancer center: 1998-2009.
M. Campo (2010)
10.1016/0305-7372(86)90015-0
Concomitant illness in patients treated for Hodgkin's disease.
M. Bookman (1986)
10.1007/s12032-009-9330-9
Infections in acute myeloid leukemia: an analysis of 382 febrile episodes
A. Gupta (2010)
10.1002/jso.2930050412
Pseudomonas meningitis complicating radical resection for radiorecurrent cancer of the paranasal sinuses: Report of two patients successfully treated with intrathecal polymyxin
G. Geelhoed (1973)
10.1002/cncr.2820360612
Intensity of immunosuppressive therapy and the incidence of pneumocystis carinii pneumonitis
W. Hughes (1975)
10.1155/2011/152430
Involvement of Activating NK Cell Receptors and Their Modulation in Pathogen Immunity
F. Marras (2011)
10.7326/0003-4819-114-9-818_5
Principles and Practice of Infectious Diseases
G. Mandell (1979)
10.1007/978-1-4613-1239-0
Infectious Complications of Cancer
J. Klastersky (1995)
Fatal Yersinia enterocolitica sepsis after blood transfusion
Wright Dc (1985)
[Incidence and surgical wound infection risk factors in breast cancer surgery].
D. Lefebvre (2000)
10.1016/B978-1-4557-4801-3.00309-X
309 – Infections in the Immunocompromised Host: General Principles
Joseph P. Donnelly (2015)
10.1097/00007890-198743060-00012
Positive effect of prophylactic total parenteral nutrition on long-term outcome of bone marrow transplantation.
S. Weisdorf (1987)
10.1007/BF01962067
Impact of the changing epidemiology of fungal infections in the 1990s
M. Pfaller (2005)
10.1086/427331
Challenges in the treatment of infections caused by gram-positive and gram-negative bacteria in patients with cancer and neutropenia.
K. Rolston (2005)
10.1056/NEJM199305063281808
Management of fever in patients with cancer and treatment-induced neutropenia.
P. Pizzo (1993)
10.1056/NEJM196911202812101
Changing pharyngeal bacterial flora of hospitalized patients. Emergence of gram-negative bacilli.
W. Johanson (1969)
A biostatistical evaluation of complications from mastectomy.
C. Say (1974)
10.1093/infdis/153.3.478
Risk factors for cytomegalovirus infection after human marrow transplantation.
J. Meyers (1986)
10.1136/bmj.1.5799.527
Cell-mediated Immune Responses in Chronic Liver Diseases
M. Smith (1972)
Opportunistic invasive fungal infections in patients with leukaemia lymphoma.
J. Krick (1976)
10.1097/PRS.0b013e31828bd377
Infection following Implant-Based Reconstruction in 1952 Consecutive Breast Reconstructions: Salvage Rates and Predictors of Success
R. Reish (2013)
10.1111/ajt.13293
Advisory Committee on Immunization Practices Recommended Immunization Schedules for Persons Aged 0 Through 18 Years — United States, 2015
R. Strikas (2015)



This paper is referenced by
10.7739/jkafn.2020.27.1.12
Cancer Care Facilities Nurses Experience of Infection Control
Yong Hwan Hyeon (2020)
10.22376/IJPBS.2017.8.4.B65-69
Bacteriological profile and antimicrobial susceptibility pattern of eskape pathogens in blood culture isolated from a tertiary care centre
Sugantha Valli.M (2017)
10.1101/386193
Risk Factors Contributing to Bacteraemia at a Tertiary Cancer Center in South Asia
Sonali Lakshika Anne Lenaduwe (2018)
10.1177/1049909119855617
Increased Length of Stay Associated With Antibiotic Use in Older Adults With Advanced Cancer Transitioned to Comfort Measures
R. Datta (2019)
10.11648/J.AJBLS.20150302.13
Analysis of GNB Species and Pattern of Resistance Responsible for LRTI in Patients with Cancer
Salwa Selim Afifi (2015)
10.1007/s15015-019-0004-y
Der septische hämatoonkologische Patient auf der Intensivstation
Vanessa Priesner (2019)
10.1016/J.EJCDT.2017.09.001
Assessment of radiological pulmonary shadows in patients with extra pulmonary neoplasm
Ahmed Mohamed Said (2017)
Extended posterior vertical axillary thoracotomy
E. Guevara (2020)
10.1016/j.heliyon.2019.e02228
Intestinal parasitism in pediatric oncology children receiving chemotherapy: unexpected low prevalence
A. El-Badry (2019)
10.1371/journal.pone.0152996
CIP2A Promotes T-Cell Activation and Immune Response to Listeria monocytogenes Infection
C. Côme (2016)
10.1155/2017/1073146
Pneumocystis Pneumonia in Non-HIV Pregnant Women Receiving Chemotherapy for Malignant Lymphoma: Two Case Reports
Yuki Fukutani (2017)
10.1186/s13104-018-3204-1
Higher cut-off serum procalcitonin level for sepsis diagnosis in metastatic solid tumor patients
Segal Abdul Aziz (2018)
10.1016/j.jinf.2016.04.003
Infection-related hospitalizations in breast cancer patients: Risk and impact on prognosis.
J. Brand (2016)
10.1007/s11046-016-0044-1
Coccidioidomycosis in Patients with Selected Solid Organ Cancers: A Case Series and Review of Medical Literature
Colin Fitterer (2016)
10.18535/jmscr/v5i12.148
A Comprehensive Overview of Staphylococcus aureus Isolates from Cancer Patients
B. Sumathi (2017)
10.20546/IJCMAS.2016.510.068
Bacterial Pathogens of Surgical Site Infections in Cancer Patients at a Tertiary Regional Cancer Centre, South India
B. G. Sumathi (2016)
Use of procalcitonin in clinical oncology: a literature review.
Andrea Sbrana (2016)
10.1038/s41598-019-51635-6
Primary renal lymphoma: a population-based study in the United States, 1980–2013
Jia-yuan Chen (2019)
10.1002/cncr.32063
Noncancer mortality among adolescents and young adults with cancer
Chelsea Anderson (2019)
10.21320/2500-2139-2019-12-4-461-467
Role of Biochemical Inflammatory Markers in Patients with Chemotherapy-Induced Neutropenia
YuN Dubinina (2019)
10.4137/BMI.S22430
Risk of Infectious Complications in Hemato-Oncological Patients Treated with Kinase Inhibitors
M. Reinwald (2015)
10.1093/annonc/mdw053
Cancer-associated toll-like receptor modulation and insinuation in infection susceptibility: association or coincidence?
A. A. Khan (2016)
Health outcomes of women with breast cancer
E. Colzani (2014)
10.2147/IDR.S183283
Bacterial profile, antibiotic resistance pattern and associated factors among cancer patients at University of Gondar Hospital, Northwest Ethiopia
Alelign Fentie (2018)
10.1016/j.tips.2019.09.006
Combating Human Pathogens and Cancer by Targeting Phosphoinositides and Their Metabolism.
Thanh Kha Phan (2019)
10.1016/j.tim.2017.06.006
Impact of the Microbiota on Bacterial Infections during Cancer Treatment.
J. Galloway-Peña (2017)
10.1093/mmy/myy138
A clinical approach to respiratory disease in patients with hematological malignancy, with a focus on respiratory infection
J. Periselneris (2019)
10.4103/ijnmr.IJNMR_228_16
A Survey of Nurses' Compliance with Hand Hygiene Guidelines in Caring for Patients with Cancer in a Selected Center of Isfahan, Iran, in 2016
M. Mostafazadeh-Bora (2018)
ANTIBACTERIAL RESISTANCE PATTERN IN ORGANISMS ISOLATED FROM SKIN AND SOFT TISSUE INFECTIONS IN CANCER PATIENTS : OBSERVATIONS FROM A TERTIARY CARE HOSPITAL
Ramakrishna Pai Jakribettu (2017)
Pulmonary Tuberculosis in a Cancer Chemotherapy Patient: Experiences and Lessons Learnt
Aparna Sharma (2015)
10.3892/ijo.2019.4669
Cancer-associated stroke: Pathophysiology, detection and management (Review)
E. Dardiotis (2019)
10.1007/978-3-030-19007-1_41
Minimally Invasive Surgery for Spinal Tumors
Zach Pennington (2019)
See more
Semantic Scholar Logo Some data provided by SemanticScholar